Logo
 
Chat Here
Chat Here
Peer review
paper published
by GAP

Medical writing,
Clinical Expertise,
Technical Development
is our core
competency

Data Safety
Monitoring Board
(DSMB)

DSMB

Clinical
Events
Committee

CEC

Safety
Assessment
Committees

SAC

Message
from
the CEO

President
and
Co-founder

Our
Service
Card

Business
Card

Automated
Remote Data Manage
QC and Medical
Monitoring
Service

Business
Card

We wrote
the book
On
GPV & E

Pharmacovigilance
is
What We Do.

We wrote
the book
On
Immuno-Oncology

Oncology-Clinical
Devlopment
is
What We Do.

javascript


Specific Conjugate Particle (SCP), The Bioavailability Boosting Technology


SCP- Technology is a novel modality that provides enhanced solubility of chemotherapeutic agents; in addition to the class III- IV compounds, better penetration into cancerous tissues and overcome natural physiologic barriers (e.g. Blood Brain Barrier) with additional synergistic effect on non-chemotherapeutic inhibitors for cellular pathways that keep the tumor cells resistant to conventional treatment. This technology creates an entirely new physical entities (NPEs) with the boosted solubility profiles. These NPEs are fashioned by flouting down the crystalline structures of the drug into micro- protected drug particles that are alleviated in a transporter system to preserve the drug in its actuated form for the duration of its shelf life. Advantages of SCP Bioavailability Augmentation Technology:


SCP- technology provides the absolute mechano-chemical and solvent-induced activation. Thus, it converts drugs to their stabilized, thermodynamically activated state. It provides flexibility and enable the technology to be applied to a range of compounds with different characteristics.

This technology is a game changer in Oncology:


SCP- Technology answers it all.





Contact us for more information.